Main Menu
Menu

Resources

Publish Date
Resources
Public Comments
Public Comments on 2024 Guidance Update on Patent Subject Matter Eligibility, Including on Artificial Intelligence
Resources
Reports
Overview of the USPTO Drug Exclusivity Report
Resources
Letters
C4IP Letter to Senate HELP Committee on the Medication Affordability and Patent Integrity Act

Dear Chairman Sanders and Ranking Member Cassidy: I write on behalf of the Council for Innovation Promotion (C4IP) to voice our organization’s...

Resources
Public Comments
Public Comments on The Impact of the Proliferation of Artificial Intelligence on Prior Art, the Knowledge of a Person Having Ordinary Skill in the Art, and Determinations of Patentability Made in View of the Foregoing (PTO-P-2023-0044)
Resources
Letters
C4IP Letter to House Judiciary Committee on IP Litigation and the U.S. International Trade Commission

Dear Chairmans Jordan and Issa and Ranking Members Nadler and Johnson: On behalf of the Council for Innovation Promotion (C4IP), I write...

Resources
Public Comments
Public Comments on Terminal Disclaimer Practice to Obviate Nonstatutory Double Patenting (PTO-P-2024-0003)
Resources
Public Comments
Public Comments on Patent Trial and Appeal Board Rules of Practice for Briefing Discretionary Denial Issues, and Rules for 325(d) Considerations, Instituting Parallel and Serial Petitions, and Termination Due to Settlement Agreement (PTO-P-2023-0048)
Resources
Public Comments
Public Comments on Rules Governing Director Review of Patent Trial and Appeal Board Decisions (PTO-P-2024-0014)
Resources
Letters
C4IP Letter to House Judiciary Committee on SHOP SAFE Act

Dear Ranking Member Nadler, Subcommittee Chairman Issa, Subcommittee Ranking Member Johnson, and Subcommittee Member Cline: The Council for Innovation Promotion is a...

Resources
Letters
C4IP Letter to House Judiciary Committee on Third-Party Litigation Funding

Dear Chairman Jordan and Ranking Member Nadler, Subcommittee Chairman Issa and Ranking Member Johnson: On behalf of the Council for Innovation Promotion...

Resources
Letters
C4IP Letter to Senate Judiciary Committee on the PREVAIL Act

Dear Chairman Durbin and Ranking Member Graham, On behalf of the Council for Innovation Promotion, we are writing to express our strong...

Resources
Letters
C4IP Letter to Senate Judiciary Committee on 5/21 Hearing on Drug Prices

Dear Chairman Durbin and Ranking Member Graham: On behalf of the Council for Innovation Promotion (C4IP), we write in advance of your...

Resources:

Resources:

Public Comments on 2024 Guidance Update on Patent Subject Matter Eligibility, Including on Artificial Intelligence,

09/16/2024
Resources:

Resources:

Overview of the USPTO Drug Exclusivity Report,

09/12/2024
Resources:

Resources:

C4IP Letter to Senate HELP Committee on the Medication Affordability and Patent Integrity Act,

08/26/2024
Resources:

Resources:

Public Comments on The Impact of the Proliferation of Artificial Intelligence on Prior Art, the Knowledge of a Person Having Ordinary Skill in the Art, and Determinations of Patentability Made in View of the Foregoing (PTO-P-2023-0044),

07/29/2024
Resources:

Resources:

C4IP Letter to House Judiciary Committee on IP Litigation and the U.S. International Trade Commission,

07/22/2024
Resources:

Resources:

Public Comments on Terminal Disclaimer Practice to Obviate Nonstatutory Double Patenting (PTO-P-2024-0003),

07/09/2024
Resources:

Resources:

Public Comments on Patent Trial and Appeal Board Rules of Practice for Briefing Discretionary Denial Issues, and Rules for 325(d) Considerations, Instituting Parallel and Serial Petitions, and Termination Due to Settlement Agreement (PTO-P-2023-0048),

06/18/2024
Resources:

Resources:

Public Comments on Rules Governing Director Review of Patent Trial and Appeal Board Decisions (PTO-P-2024-0014),

06/17/2024
Resources:

Resources:

C4IP Letter to House Judiciary Committee on SHOP SAFE Act,

06/13/2024
Resources:

Resources:

C4IP Letter to House Judiciary Committee on Third-Party Litigation Funding,

06/12/2024
Resources:

Resources:

C4IP Letter to Senate Judiciary Committee on the PREVAIL Act,

06/10/2024
Resources:

Resources:

C4IP Letter to Senate Judiciary Committee on 5/21 Hearing on Drug Prices,

05/20/2024
Scroll to Top